Engimmune Therapeutics Announces the Appointment of Dr Annalisa D'Andrea to its Board of Directors

/PRNewswire/ -- Engimmune Therapeutics AG ("Engimmune"), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, is pleased to...

Related Keywords

Italy ,United States ,California ,Switzerland ,Swiss ,American ,Annalisa Dandrea ,Kiniksa Pharmaceuticals ,University Of Pennsylvania ,Venture Partner At Longwood Fund ,Bachelor Of Sciences ,Novartis ,Wistar Institute ,University Of Siena ,Research Institute In Palo Alto ,University Of Florence ,Venture Partner ,Longwood Fund ,Chief Scientific Officer ,Vice President ,Global Head ,Executive Director ,Section Head ,Ddiscovery Biology ,Chiron Vaccines ,Palo Alto ,Annalisad Andrea ,Engimmune Therapeutics ,